GENERAL COMMENTS
This is an important study that tracks the trial registrationpublication lag time of trials on appendicitis. However there is a lack of clarity in some aspects of the methods, which to me has affected the validity of the findings. First and foremost, did the authors allow a "grace period" between study completion and publication (which means submission +/-rejection +/-revision/s + acceptance + editorial processing time)? It appears unclear to me whether this was taken into consideration although I suspect not, as the latest date of search was May 2016, and the the study was completed in 2016, while on average several months to a year may lapse before a completed study is finally published. It is unrealistic to expect most completed trials to be in print within 6 months of completion. Not sure whether the authors can tease out those studies that were considered "too new" and re-analyse, if not, they will need to acknowledge this as a limitation.
Next, the authors examined the association between topics of study and publication status, which is valuable. I do not see any assessment on the association of the direction of study results and publication status, which is an important question to be answered, as it is proven in research in other fields that positive trials are more likely to be published than negative trials. Were the results of all trials made available in the trial registry? Next, some minor nut important details need to be included in the methodology, including the exact date of search for each repository, and the exact key terms used in search, to make the study reproducible. Additionally, some statements need further clarification, like "barriers to rapid publication" for example. How did the author define "rapid publication"? What kind of barrier were the authors looking for that might be present within the information provide in the trial registry?
Lastly, care need to be taken i formatting and presentation of results, for instance, in the last sentence of the results in the abstract, there seems to be some formatting error. 
REVIEWER

Simon Craig
REVIEW RETURNED
12-Feb-2018
GENERAL COMMENTS
Thank you for the opportunity to review this interesting paper on the publication status of completed registered studies in paediatric appendicitis. Overall, the paper is clearly written, has sensible methodology (although perhaps an incomplete search of clinical trial registries) and draws appropriate conclusions from the data. In terms of specific comments regarding the manuscript, may main concerns relate to completeness of the data collection (only one registry used), and the relatively long duration between close of database and the date of this review:
(1) The database closed in May 2016. It is now February 2018. I am concerned that the study regarding publication status is therefore considerably out of date. It may be worth running the search again to identify any additional publications.
(2) The authors state that authors of unpublished studies were contacted. However, the results do not indicate whether attempts were made to contact all authors, and do not provide information on how many replied to the contact. (3) The authors assert that clinicaltrials.gov is the largest and most widely used database, but do not provide a reference supporting this. Another very useful resource is the clinical trials registry platform maintained by the World Health Organisation (http://apps.who.int/trialsearch/). To provide a comprehensive overview of registered trials in this area, I would suggest looking at this registry as well. (4) There are a few minor typographic errors (e.g. top line of page 8 -"drom" instead of "from")
REVIEWER
Tristan Reddan
REVIEW RETURNED
14-Feb-2018
GENERAL COMMENTS
Thank you for the opportunity to review what it is an interesting and important manuscript highlighting potential bias in the body of evidence in the diagnosis and management of paediatric appendicitis.
It would be interesting to consider how the proportion of unpublished studies and time to publication in studies of paediatric appendicitis compare more broadly to other topics.
• Line 18 -Consider changing "What is the consequence of ambiguity? Until overwhelming evidence …" to read "Without overwhelming evidence for or against an intervention". Line 25 -change "be easier adopted" to "more easily adopted" Line 27 -"Professional mentality …" These two sentences are quite subjective and are not supported by any evidence or reference.
STROBE Checklist -consider including manuscript page numbers on checklist as per guidelines available at http://www.equatornetwork.org/reporting-guidelines/strobe/
VERSION 1 -AUTHOR RESPONSE
Reviewer: 1 Comment 1: "This is an important study that tracks the trial registration-publication lag time of trials on appendicitis. However there is a lack of clarity in some aspects of the methods, which to me has affected the validity of the findings. First and foremost, did the authors allow a "grace period" between study completion and publication (which means submission ± rejection ± revision/s + acceptance + editorial processing time)? It appears unclear to me whether this was taken into consideration although I suspect not, as the latest date of search was May 2016, and the the study was completed in 2016, while on average several months to a year may lapse before a completed study is finally published. It is unrealistic to expect most completed trials to be in print within 6 months of completion. Not sure whether the authors can tease out those studies that were considered "too new" and re-analyse, if not, they will need to acknowledge this as a limitation." Answer 1: We thank the reviewer for this comment and we have added a statement to the limitations section.
Comment 2: "Next, the authors examined the association between topics of study and publication status, which is valuable. I do not see any assessment on the association of the direction of study results and publication status, which is an important question to be answered, as it is proven in research in other fields that positive trials are more likely to be published than negative trials. Were the results of all trials made available in the trial registry?" Answer 2: We concur with the reviewer that a comparison of study outcomes between published and unpublished studies would be very interesting. Unfortunately, the direction of results are not available for the unpublished studies, therefore a comparison is not possible.
Comment 3: "Next, some minor nut important details need to be included in the methodology, including the exact date of search for each repository, and the exact key terms used in search, to make the study reproducible." Answer 3: Thank you for this comment. We have expanded the methods section "search for publications and completed studies" Comment 4: "Additionally, some statements need further clarification, like "barriers to rapid publication" for example. How did the author define "rapid publication"? What kind of barrier were the authors looking for that might be present within the information provide in the trial registry?" Answer 4: We clarified the wording (Page 9 line 7). There is no information on barriers to publication in clinicaltrials.gov. Comment 5: "Lastly, care need to be taken i formatting and presentation of results, for instance, in the last sentence of the results in the abstract, there seems to be some formatting error." Answer 5: the phrase was corrected Reviewer: 2 Comment 1: This paper addressed an interesting question about the overall scientific value of the currently available publications regarding paediatric appendicitis. The authors made a conclusion that a certain degree of scientific uncertainty exists due to a lot of clinical trial results remain unpublished. The result is interesting and likely leads to further discussion among readers. However, it has little influence on daily clinical practice and I suggest the authors to add a short paragraph about the clinical relevance of the findings. I think one of the major reasons that many trial results were not published is because they were rejected by journals, especially those who got repeated rejection. Although most proper trials will be registered in the clinicaltrials.gov, there are many well-organized studies which are not registered. It seems that studies about diagnostic criteria have the highest publication rate and is there any particular reason for that? Answer 1: We thank the reviewer for this comment. We have added a sentence to the limitations section that unregistered studies were not captured in this analysis. About the clinical relevance of underreporting of negative results and the high rate of publication for studies on diagnostic criteria can only be speculated on. It is possible that diagnostic studies are methodologically easier to conduct. The clinical main relevance of the finding is that the practicing clinician be aware of possible scientific uncertainty due to unpublished clinical study results. We have clarified this statement in the conclusion section. Please see also reviewer 4 comment 1.
Comment 2: Perhaps, the authors can also analyze if there is a difference in the publication rate between different countries. Answer 2: Thank you for this comment. We added this analysis to the manuscript.
Reviewer: 3 Comment 1: The database closed in May 2016. It is now February 2018. I am concerned that the study regarding publication status is therefore considerably out of date. It may be worth running the search again to identify any additional publications. Answer 1: We agree with the reviewer that it would be of interest to analyze progress on data transparency. We have therefore added a sentence to the discussion stating "The present data serve as quantitative baseline for data transparency in pediatric appendicitis and it would be of interest to analyze progress in the future".
Comment 2: The authors state that authors of unpublished studies were contacted. However, the results do not indicate whether attempts were made to contact all authors, and do not provide information on how many replied to the contact. Answer 2: We added this information in the methods section.
Comment 3: The authors assert that clinicaltrials.gov is the largest and most widely used database, but do not provide a reference supporting this. Another very useful resource is the clinical trials registry platform maintained by the World Health Organisation (http://apps.who.int/trialsearch/). To provide a comprehensive overview of registered trials in this area, I would suggest looking at this registry as well. Answer 3: we thank the reviewer for this excellent comment. We have clarified throughout the manuscript that this analyses is limited to the clinicaltrials.gov database.
Comment 4: There are a few minor typographic errors (e.g. top line of page 8 -"drom" instead of "from") Answer 4: typographical errors were corrected. Introduction Line 14 Para 1 Sentences 2&3 -Consider combining "…controversies continue to exist and challenges remain." Line 46 Para 2 Sentence 3 -delete "as outlined above" , restating the list of issues is reasonable and "as outlined above" makes it feel repetitive. Answer: done Answer: done Line 18 -Consider changing "What is the consequence of ambiguity? Until overwhelming evidence …" to read "Without overwhelming evidence for or against an intervention". Answer: done Line 25 -change "be easier adopted" to "more easily adopted" Answer: done Line 27 -"Professional mentality …" These two sentences are quite subjective and are not supported by any evidence or reference. Answer: we have softened the language to account for the correct statement of the reviewer that this phrase is somewhat speculative Comment 3: STROBE Checklist -consider including manuscript page numbers on checklist as per guidelines available at http://www.equator-network.org/reporting-guidelines/strobe/ Answer 3: the manuscript page numbers were included in the checklist 
GENERAL COMMENTS
Most of the previous comments have been addressed. Congratulations to the authors for the good work.
REVIEWER
Simon Craig
REVIEW RETURNED
17-Apr-2018
GENERAL COMMENTS
Thank you for submitting a revised manuscript, which reads very well, and addresses all of the concerns that I raised in my initial review.
There is one reference which should be corrected -top line of page 8, you have listed a pubmed citation number and not provided the reference (which, I believe, is "J Pearn: Publication, an ethical imperative. BMJ 1995 May 20; 310(6990): 1313-1315. Once this is addressed, I would be happy to recommend this paper for publication.
REVIEWER
Tristan Reddan
REVIEW RETURNED
21-Apr-2018
GENERAL COMMENTS
Thank you for the opportunity to review your revised manuscript, suggestions of previous reviewers have been addressed, and the paper subsequently improved. There are limitations that have been identified and declared to acknowledge the potential lag in publication of results after database closure which is impossible to perfectly overcome with the delays inherent to publishing the results of this analysis. There is a minor grammatical error (p9 Line 14 -should be "Median" rather than "Media". Thank you for your contribution to the body of knowledge on this important topic.
VERSION 2 -AUTHOR RESPONSE
Reviewer: 3 Comment: There is one reference which should be corrected -top line of page 8, you have listed a pubmed citation number and not provided the reference (which, I believe, is "J Pearn: Publication, an ethical imperative. BMJ 1995 May 20; 310(6990): 1313-1315. Once this is addressed, I would be happy to recommend this paper for publication. Answer: corrected.
Reviewer: 4 Comment: There is a minor grammatical error (p9 Line 14 -should be "Median" rather than "Media". Thank you for your contribution to the body of knowledge on this important topic. Answer: corrected.
